Membership Directory
Alkermes, Inc.
Category: Drug Development
Phone: +1 (781) 609-6000
Website: http://www.alkermes.com
Location: Waltham, MA
Alkermes, Inc. is an emerging pharmaceutical company developing products based on its sophisticated drug delivery technologies to enhance therapeutic outcomes. Our areas of focus include: controlled, extended-release of injectable drugs utilizing our ProLease® and Medisorb® delivery systems and the development of inhaled pharmaceutical products based on our proprietary AIR® pulmonary delivery system. Our business
strategy is twofold. We partner our proprietary technology systems and drug delivery expertise with many of the world's finest pharmaceutical companies and also develop novel, proprietary drug candidates for our own account. In addition to our Massachusetts headquarters, research and manufacturing facilities, we operate research and manufacturing facilities in Ohio.
MassBio Member News
- September 8, 2010 4s3 Bioscience joins VDC
- August 18, 2010 NEU's new weight-loss compound shows promise
- August 17, 2010 TraceLink Partners with Patheon to Optimize Life Science Contract Manufacturing Performance
- August 17, 2010 Lucille C. Servidio Appointed to Board of Directors for CMBEN
- July 30, 2010 Boston Biomedical Research Institute Announces A New Alzheimer's Collaboration
Upcoming Events
- September 10, 2010 16th Annual Golf Classic: Tee Off for Biotechnology Education
- September 13, 2010 16th Annual Biotech Symposium
- September 14, 2010 Medicon Valley (Denmark & Sweden) Biotech Day at MassBio
- September 14, 2010 French Biotech Tour
- September 15, 2010 BioPharm America 2010 Featuring the MassBio Investors Forum
